BIOMARKER:

CBL mutation

Entrez ID:

Related biomarkers:

‹

›

CBL mutation CBL mutation	Acute Myelogenous Leukemia AML	gilteritinib Resistant: B - Late Trials
CBL mutation CBL mutation	Acute Myelogenous Leukemia AML	cytarabine/daunorubicin liposomal formulation Resistant: C3 – Early Trials
CBL mutation CBL mutation	Sarcoma Sarcoma	MGCD516 Sensitive: C3 – Early Trials
CBL mutation CBL mutation	Non Small Cell Lung Cancer NSCLC	MGCD516 Sensitive: C3 – Early Trials
CBL mutation CBL mutation	Melanoma Melanoma	MGCD516 Sensitive: C3 – Early Trials
CBL mutation CBL mutation	Non Small Cell Lung Cancer NSCLC	SU11274 Sensitive: D – Preclinical
CBL mutation CBL mutation	Chronic Myelomonocytic Leukemia CMML	dasatinib Sensitive: D – Preclinical